167 related articles for article (PubMed ID: 16290997)
21. Causes and consequences of heart failure after prophylactic implantation of a defibrillator in the multicenter automatic defibrillator implantation trial II.
Goldenberg I; Moss AJ; Hall WJ; McNitt S; Zareba W; Andrews ML; Cannom DS;
Circulation; 2006 Jun; 113(24):2810-7. PubMed ID: 16769917
[TBL] [Abstract][Full Text] [Related]
22. Implantable cardioverter-defibrillator therapy for primary prevention of sudden death after alcohol septal ablation of hypertrophic cardiomyopathy.
Cuoco FA; Spencer WH; Fernandes VL; Nielsen CD; Nagueh S; Sturdivant JL; Leman RB; Wharton JM; Gold MR
J Am Coll Cardiol; 2008 Nov; 52(21):1718-23. PubMed ID: 19007692
[TBL] [Abstract][Full Text] [Related]
23. Predictors of appropriate defibrillator therapy among patients with an implantable defibrillator that delivers cardiac resynchronization therapy.
Desai AD; Burke MC; Hong TE; Kim S; Salem Y; Yong PG; Knight BP
J Cardiovasc Electrophysiol; 2006 May; 17(5):486-90. PubMed ID: 16684019
[TBL] [Abstract][Full Text] [Related]
24. Posttraumatic stress symptoms and predicted mortality in patients with implantable cardioverter-defibrillators: results from the prospective living with an implanted cardioverter-defibrillator study.
Ladwig KH; Baumert J; Marten-Mittag B; Kolb C; Zrenner B; Schmitt C
Arch Gen Psychiatry; 2008 Nov; 65(11):1324-30. PubMed ID: 18981344
[TBL] [Abstract][Full Text] [Related]
25. Survival and appropriate device interventions in recipients of cardioverter defibrillators implanted for the primary versus secondary prevention of sudden cardiac death.
Stockburger M; Krebs A; Nitardy A; Habedank D; Celebi O; Knaus T; Dietz R
Pacing Clin Electrophysiol; 2009 Mar; 32 Suppl 1():S16-20. PubMed ID: 19250084
[TBL] [Abstract][Full Text] [Related]
26. Long-term follow-up of primary prophylactic implantable cardioverter-defibrillator therapy in Brugada syndrome.
Sarkozy A; Boussy T; Kourgiannides G; Chierchia GB; Richter S; De Potter T; Geelen P; Wellens F; Spreeuwenberg MD; Brugada P
Eur Heart J; 2007 Feb; 28(3):334-44. PubMed ID: 17251258
[TBL] [Abstract][Full Text] [Related]
27. Prognosis among survivors of primary ventricular fibrillation in the percutaneous coronary intervention era.
de Jong JS; Marsman RF; Henriques JP; Koch KT; de Winter RJ; Tanck MW; Wilde AA; Dekker LR
Am Heart J; 2009 Sep; 158(3):467-72. PubMed ID: 19699872
[TBL] [Abstract][Full Text] [Related]
28. Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy?
Ellenbogen KA; Levine JH; Berger RD; Daubert JP; Winters SL; Greenstein E; Shalaby A; Schaechter A; Subacius H; Kadish A;
Circulation; 2006 Feb; 113(6):776-82. PubMed ID: 16461817
[TBL] [Abstract][Full Text] [Related]
29. Role of the implantable defibrillator among elderly patients with a history of life-threatening ventricular arrhythmias.
Healey JS; Hallstrom AP; Kuck KH; Nair G; Schron EP; Roberts RS; Morillo CA; Connolly SJ
Eur Heart J; 2007 Jul; 28(14):1746-9. PubMed ID: 17283003
[TBL] [Abstract][Full Text] [Related]
30. Implantable cardioverter defibrillators and Chagas' disease: results of the ICD Registry Latin America.
Muratore CA; Batista Sa LA; Chiale PA; Eloy R; Tentori MC; Escudero J; Lima AM; Medina LE; Garillo R; Maloney J
Europace; 2009 Feb; 11(2):164-8. PubMed ID: 19056745
[TBL] [Abstract][Full Text] [Related]
31. The ABCD (Alternans Before Cardioverter Defibrillator) Trial: strategies using T-wave alternans to improve efficiency of sudden cardiac death prevention.
Costantini O; Hohnloser SH; Kirk MM; Lerman BB; Baker JH; Sethuraman B; Dettmer MM; Rosenbaum DS;
J Am Coll Cardiol; 2009 Feb; 53(6):471-9. PubMed ID: 19195603
[TBL] [Abstract][Full Text] [Related]
32. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S
Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697
[TBL] [Abstract][Full Text] [Related]
33. [The implantable cardioverter-defibrillator and hypertrophic cardiomyopathy. Experience at three centers].
Marín F; Gimeno JR; Payá E; García-Alberola A; Pérez-Alvarez L; Fernández X; de la Morena G; Sogorb F; Castro-Beiras A; Valdés M; Martínez JG; Monserrat L
Rev Esp Cardiol; 2006 Jun; 59(6):537-44. PubMed ID: 16790196
[TBL] [Abstract][Full Text] [Related]
34. Benefit of combined resynchronization and defibrillator therapy in heart failure patients with and without ventricular arrhythmias.
Ypenburg C; van Erven L; Bleeker GB; Bax JJ; Bootsma M; Wijffels MC; van der Wall EE; Schalij MJ
J Am Coll Cardiol; 2006 Aug; 48(3):464-70. PubMed ID: 16875970
[TBL] [Abstract][Full Text] [Related]
35. Death without prior appropriate implantable cardioverter-defibrillator therapy: a competing risk study.
Koller MT; Schaer B; Wolbers M; Sticherling C; Bucher HC; Osswald S
Circulation; 2008 Apr; 117(15):1918-26. PubMed ID: 18391108
[TBL] [Abstract][Full Text] [Related]
36. Shocks, personality, and anxiety in patients with an implantable defibrillator.
Van den Broek KC; Nyklícek I; Van der Voort PH; Alings M; Denollet J
Pacing Clin Electrophysiol; 2008 Jul; 31(7):850-7. PubMed ID: 18684282
[TBL] [Abstract][Full Text] [Related]
37. Significance of inducible ventricular flutter/fibrillation in risk stratification in patients with coronary artery disease.
Matsushita T; Chun S; Liem LB; Friday KJ; Sung RJ
Int J Cardiol; 2004 Mar; 94(1):67-71. PubMed ID: 14996477
[TBL] [Abstract][Full Text] [Related]
38. Atrial fibrillation predicts appropriate shocks in primary prevention implantable cardioverter-defibrillator patients.
Smit MD; Van Dessel PF; Rienstra M; Nieuwland W; Wiesfeld AC; Tan ES; Anthonio RL; Van Veldhuisen DJ; Van Gelder IC
Europace; 2006 Aug; 8(8):566-72. PubMed ID: 16864611
[TBL] [Abstract][Full Text] [Related]
39. Implantable cardioverter defibrillator therapy in adults with congenital heart disease: who is at risk of shocks?
Koyak Z; de Groot JR; Van Gelder IC; Bouma BJ; van Dessel PF; Budts W; van Erven L; van Dijk AP; Wilde AA; Pieper PG; Sieswerda GT; Mulder BJ
Circ Arrhythm Electrophysiol; 2012 Feb; 5(1):101-10. PubMed ID: 22095638
[TBL] [Abstract][Full Text] [Related]
40. Device complications and inappropriate implantable cardioverter defibrillator shocks in patients with hypertrophic cardiomyopathy.
Lin G; Nishimura RA; Gersh BJ; Phil D; Ommen SR; Ackerman MJ; Brady PA
Heart; 2009 May; 95(9):709-14. PubMed ID: 19282314
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
